Francois Cachat1, Christophe Combescure2, Michel Cauderay3, Eric Girardin4, Hassib Chehade5. 1. Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Lausanne, Switzerland; francois.cachat@chuv.ch. 2. CRC and Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva University Hospitals of Geneva, Geneva, Switzerland; 3. Department of Pediatrics, Pediatric Endocrinology Unit, Samaritain Regional Hospital, Vevey, Switzerland; and. 4. Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Geneva, Switzerland. 5. Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Lausanne, Switzerland;
Abstract
BACKGROUND AND OBJECTIVES: Evaluation of glomerular hyperfiltration (GH) is difficult; the variable reported definitions impede comparisons between studies. A clear and universal definition of GH would help in comparing results of trials aimed at reducing GH. This study assessed how GH is measured and defined in the literature. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Three databases (Embase, MEDLINE, CINAHL) were systematically searched using the terms "hyperfiltration" or "glomerular hyperfiltration". All studies reporting a GH threshold or studying the effect of a high GFR in a continuous manner against another outcome of interest were included. RESULTS: The literature search was performed from November 2012 to February 2013 and updated in August 2014. From 2013 retrieved studies, 405 studies were included. Threshold use to define GH was reported in 55.6% of studies. Of these, 88.4% used a single threshold and 11.6% used numerous thresholds adapted to participant sex or age. In 29.8% of the studies, the choice of a GH threshold was not based on a control group or literature references. After 2004, the use of GH threshold use increased (P<0.001), but the use of a control group to precisely define that GH threshold decreased significantly (P<0.001); the threshold did not differ among pediatric, adult, or mixed-age studies. The GH threshold ranged from 90.7 to 175 ml/min per 1.73 m(2) (median, 135 ml/min per 1.73 m(2)). CONCLUSION: Thirty percent of studies did not justify the choice of threshold values. The decrease of GFR in the elderly was rarely considered in defining GH. From a methodologic point of view, an age- and sex-matched control group should be used to define a GH threshold.
BACKGROUND AND OBJECTIVES: Evaluation of glomerular hyperfiltration (GH) is difficult; the variable reported definitions impede comparisons between studies. A clear and universal definition of GH would help in comparing results of trials aimed at reducing GH. This study assessed how GH is measured and defined in the literature. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Three databases (Embase, MEDLINE, CINAHL) were systematically searched using the terms "hyperfiltration" or "glomerular hyperfiltration". All studies reporting a GH threshold or studying the effect of a high GFR in a continuous manner against another outcome of interest were included. RESULTS: The literature search was performed from November 2012 to February 2013 and updated in August 2014. From 2013 retrieved studies, 405 studies were included. Threshold use to define GH was reported in 55.6% of studies. Of these, 88.4% used a single threshold and 11.6% used numerous thresholds adapted to participant sex or age. In 29.8% of the studies, the choice of a GH threshold was not based on a control group or literature references. After 2004, the use of GH threshold use increased (P<0.001), but the use of a control group to precisely define that GH threshold decreased significantly (P<0.001); the threshold did not differ among pediatric, adult, or mixed-age studies. The GH threshold ranged from 90.7 to 175 ml/min per 1.73 m(2) (median, 135 ml/min per 1.73 m(2)). CONCLUSION: Thirty percent of studies did not justify the choice of threshold values. The decrease of GFR in the elderly was rarely considered in defining GH. From a methodologic point of view, an age- and sex-matched control group should be used to define a GH threshold.
Authors: Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Jane S Hankins; Russell E Ware Journal: Pediatr Nephrol Date: 2011-05-11 Impact factor: 3.714
Authors: Shih-Han S Huang; Ajay P Sharma; Abeer Yasin; Robert M Lindsay; William F Clark; Guido Filler Journal: Clin J Am Soc Nephrol Date: 2010-10-21 Impact factor: 8.237
Authors: M C Thomas; J L Moran; V Harjutsalo; L Thorn; J Wadén; M Saraheimo; N Tolonen; J Leiviskä; A Jula; C Forsblom; P H Groop Journal: Diabetologia Date: 2012-02-10 Impact factor: 10.122
Authors: Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles Journal: J Am Soc Nephrol Date: 2017-01-31 Impact factor: 10.121
Authors: Harini A Chakkera; Aleksandar Denic; Walter K Kremers; Mark D Stegall; Joseph J Larson; Harish Ravipati; Sandra J Taler; John C Lieske; Lilach O Lerman; Joshua J Augustine; Andrew D Rule Journal: Nephrol Dial Transplant Date: 2020-06-01 Impact factor: 5.992